Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

2.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

3.

Study finds 81% of cancer cures touted by TikTok videos are fake

4.

Loneliness and social isolation linked to heightened risk of death in those with cancer

5.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot